Once optimal levels are achieved, a maintenance schedule of one treatment every few weeks is often recommended
Theres been very little human data to show a benefit from unapproved peptides, says Daniel M
Acta Medica Port 26(4):341348 de Prost N, Mekontso-Dessap A, Valeyrie-Allanore L, Van Nhieu JT, Duong TA, Chosidow O, Wolkenstein P, Brun-Buisson C, Maitre B (2014) Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation
Although the FDA has yet to approve BPC 157 for medical use, the growing body of anecdotal evidence and clinical reports suggests that these peptides hold promise in a variety of treatments
and those tissues when have higher levels of histamine